Company Announcements

Notice of Results

Source: RNS
RNS Number : 5889J
Itaconix PLC
08 April 2024
 

For release: 8 April 2024

 

Itaconix plc

("Itaconix" or the "Company")

Notice of Results and Company Presentation

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, announces that its Preliminary Results for the year ended 31 December 2023 will be released on 15 April 2024.

Investor Meet Company presentation

A live presentation will be held on 15 April 2024 at 14:00 BST.  This presentation is open to all interested parties.

Anyone can sign up for free to the Investor Meet Company platform and join the live presentation via:

https://www.investormeetcompany.com/itaconix-plc/register-investor

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 April 2024, 09:00 BST, or at any time during the live presentation.

 

- Ends -

 

Itaconix plc

John R. Shaw / Laura Denner

                             +1 603 775-4400

Belvedere Communications

John West / Llew Angus

                      +44 (0)20 7653 8702

Canaccord Genuity - Nominated Adviser and Sole Broker

Adam James / Harry Pardoe

                     +44 (0) 20 7523 8000

 

About Itaconix  

 

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.  The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.   

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREAXLXESDLEFA